GOODMAN JONATHAN R. 4
4 · POINT Biopharma Global Inc. · Filed Nov 21, 2022
Insider Transaction Report
Form 4
GOODMAN JONATHAN R.
Director
Transactions
- Purchase
Common Stock
2022-11-18$6.33/sh+6,000$37,980→ 41,872 total(indirect: Long Zone Holdings, Inc.)
Footnotes (1)
- [F1]A corporation controlled by the Reporting Person.